Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-30
2006-05-30
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S554000, C540S557000
Reexamination Certificate
active
07053083
ABSTRACT:
The present invention provides compounds of the general formulas:wherein Y is NR or —(CH2)n; R is H or alkyl “Z” represents optionally substituted phenyl or a 6-membered aromatic ring having one nitrogen atom; “W” represents a optionally substituted phenyl or 5-membered aromatic ring having one nitrogen atom; “X” represents an optionally substituted 5-membered aromatic ring having one sulfur atom; as well as methods and pharmaceutical compositions utilizing these compounds for the inducing temporary delay of urination or treatment of disorders remedied by vasopressin agonist activity, including diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders.
REFERENCES:
patent: 5516774 (1996-05-01), Albright
patent: 5521173 (1996-05-01), Venkatesan
patent: 5532235 (1996-07-01), Albright
patent: 5536718 (1996-07-01), Albright
patent: 5610156 (1997-03-01), Albright
patent: 5612334 (1997-03-01), Albright
patent: 5624923 (1997-04-01), Albright
patent: 5654297 (1997-08-01), Albright
patent: 5686445 (1997-11-01), Albright
patent: 5693635 (1997-12-01), Albright
patent: 5696112 (1997-12-01), Albright
patent: 5700796 (1997-12-01), Albright
patent: 5719278 (1998-02-01), Albright
patent: 5733905 (1998-03-01), Albright
patent: 5736538 (1998-04-01), Albright
patent: 5736540 (1998-04-01), Albright
patent: 5739128 (1998-04-01), Albright
patent: 5747487 (1998-05-01), Albright
patent: 5753648 (1998-05-01), Albright
patent: 5760031 (1998-06-01), Albright
patent: 5780471 (1998-07-01), Venkatesan
patent: 5849735 (1998-12-01), Albright
patent: 6096735 (2000-08-01), Ogawa et al.
patent: 6096736 (2000-08-01), Ogawa
patent: WO 9534540 (1995-12-01), None
patent: WO 9622282 (1996-07-01), None
patent: WO 9722591 (1997-06-01), None
patent: WO 9965525 (1999-12-01), None
patent: WO 0043398 (2000-07-01), None
Kondo et al., Novel Design of Nonpeptide AVP V2 Receptor Agonists: Structural Requirements for an Agonist Having 1-(4-Aminobenzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepine as a Template, J. of Medicinal Chemistry, Nov. 2000, vol. 43, No. 23, pp. 4388-4397.
Erstad, Systemic Hemostatic Medications for Reducing Surgical Blood Loss, The Annals of Pharmacotherapy, Jul./Aug. 2001, vol. 35, pp. 925-934.
Wong et al., Desmopressin Does Not Decrease Blood Loss and Transfusion Requirements in Patients Undergoing Hepatectomy, 2003, vol. 50, No. 1, pp. 14-20.
Beitz and Schultz, Current Medicinal Chemistry, 1999, 457-467, 6.
Goodman and Gilman, The Pharmacological Basis of Therapeutics, 1996, 715-731, 9th Edition.
Lethagen, Ann. Hematol., 1994, 173-180, 69.
Cash et al., Brit. J. Haematol., 1974, 363-364, 27.
David, Regulatory Peptides, 1993, 311-317, 45.
Burggraaf et al., Cli. Sci., 1994, 497-503, 86.
Caggiano Thomas Joseph
Dusza John P.
Failli Amedeo Arturo
Memoli Kevin A.
Shumsky Jay Scott
Coleman Brenda
O'Connor Cozen
Straher Michael P.
Wyeth
LandOfFree
Cyclohexylphenyl vasopressin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclohexylphenyl vasopressin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexylphenyl vasopressin agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3624478